CClinicalTrials.gg
Status unknownNCT02218892Updated Mar 6, 2023

Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis

An observational study in Juvenile Idiopathic Arthritis and Temporomandibular Arthritis, sponsored by Malin Collin. Status unknown at 1 site in Sweden. Open to participants aged 7 Years to 14 Years. Per ClinicalTrials.gov, last updated 2023-03-06.

Sponsored by Malin Collin · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
62
Ages
7 Years to 14 Years
Sex
All
01

Study summary

Purpose and aims The general aim of this project is to improve the diagnostic methods for disease activity and identify predictive factors (clinical and radiographic factors, pro- and anti-inflammatory mediators in saliva and plasma) for temporomandibular joint (TMJ) involvement in juvenile idiopathic arthritis (JIA).

The hypothesis is that self-reported pain and impaired jaw function together with clinical findings correlates well with radiological signs of jaw involvement.

Null hypothesis: Self-reported pain, impaired jaw function and clinical findings do not correlate with radiological signs of jaw involvement.

Study 1 The aim of this study is to investigate which findings from the patient history and from clinical examination that is of significance for diagnostics of TMJ involvement in patients with JIA both in a short- and long-term perspective. The patients will be followed-up during two years. They will undergo a clinical examination according to Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD; Dworkin and LeResche 1992) once a year and a telephone follow-up sixth months after the clinical examination. Further, the clinical findings from the orofacial regions will be compared to their general disease activity.

Study 2 The aim of the second study is to correlate radiological findings and clinical findings in order to investigate any early radiological signs of disease activity and progression but also to compare the radiographic examination using conventional panoramic technique with computer tomography (CT).

Read the detailed description

One-hundred consecutive patients with active JIA, as diagnosed by the Department of Pediatric Rheumatology, Astrid Lindgrens Barnsjukhus, Karolinska University Hospital will be included.

Inclusion criteria are:

  • age between 7 and 14 years
  • a diagnosis of JIA according to the International League of Associations for rheumatology

Exclusion criteria are:

  • current malignancies
  • TMJ surgery or trauma within two years
  • recent intra-articular glucocorticoid injection in TMJ (within 1 month)
  • other conditions or diseases than JIA that may cause orofacial pain. The parents of the patients and/or the patients will give their verbal and written informed consent to participate in the study according to the permission from the regional ethical committee 2011/2:1.

Clinical examination and follow-ups The patients will be examined clinically three times with an interval of 12 months. The clinical examination will be performed according to the RDC-TMD by calibrated investigators. Panoramic x-ray and CT scans will be performed at the inclusion examination as well as at the end of the study after 24 months. Pharmacological treatment will be recorded at every clinical examination and at telephone interviews. The patients will also be examined by a pediatric rheumatologist regarding general disease activity according to the Juvenile Arthritis Disease Activity Score 27 (JADAS-27), the Short Form (36) Health Survey (SF-36), thrombocyte particle count, C-reactive protein and blood titer of rheumatoid factor and anti-cyclic citrullinated peptides. Information from the examination by the pediatric rheumatologist will be drawn from the Swedish national register for children with JIA.

Telephone interview Six months after the first and second visit, a structured telephone interview with the patients and/or their parents will be performed according to a questionnaire. The objective is to estimate the degree of joint pain and functional limitations in jaw function.

Radiological examination Conventional panoramic x-rays and bilateral TMJ images will be obtained with the digital volume tomography (DVT, New Tom Model QR-DVT 9000, New Tom AG, Marburg, Germany). The CT sections will be evaluated by a specialist in oral radiology for presence of radiographic signs of cortical and subcortical erosions, flattening, sclerosis and ramus height.

02

Conditions studied

  • Juvenile Idiopathic Arthritis
  • Temporomandibular Arthritis
03

In context

Arthritis

3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.

This study's enrollment of 62 is below the median of 155 across 1,057 observational studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

This is the only study on the registry with Malin Collin as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

One-hundred consecutive patients with active JIA, as diagnosed by the Department of Pediatric Rheumatology, Astrid Lindgrens Barnsjukhus, Karolinska University Hospital will be included.

Inclusion criteria

  1. age between 7 and 14 years
  2. a diagnosis of JIA according to the International League of Associations for rheumatology (ILAR) The parents of the patients and/or the patients will give their verbal and written informed consent to participate in the study according to the permission from the regional ethical committee 2011/2:1.

Exclusion criteria

Exclusion Criteria:

  1. current malignancies
  2. TMJ surgery or trauma within two years
  3. recent intra-articular glucocorticoid injection in TMJ (within 1 month)
  4. other conditions or diseases than JIA that may cause orofacial pain.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
62 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Juvenil Idiopathic Arthritis

    The group consists of children age 7-14 with an diagnosis of active Juvenile Idiopathic Arthritis.

06

What researchers measure

Primary outcomes

  1. Clinical findings in children with JIA

    To find similarities in patients with JIA according to RDC-TMD (a clinical protocol validated for children)

    Time frame: 2 years

  2. Radiographic findings in children with JIA

    Repeated radiographic examination

    Time frame: Two years

  3. Patient history

    Repeated interview on function and pain in the jaw area

    Time frame: Two years

07

Study locations

1 site
  • Folktandvården Stockholmslän AB
    Stockholm, 14463, Sweden
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02218892
Lead sponsor
Malin Collin
Collaborators
Karolinska Institutet
Responsible party
Malin Collin (DDS, PhD-student, Folktandvården Stockholms län AB) — Sponsor-investigator
First posted
Aug 18, 2014
Start date
Feb 2011
Primary completion
Aug 2017
Completion
Dec 2023 (estimated)
Last update
Mar 6, 2023

Study contacts

Britt Hedenberg Magnusson, PhD DDS
study director · Karolinska Institutet

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion